Gencor Pacific, Inc. has announced completion of an eight week, 60 patient double blind, randomized, placebo controlled human study on the company'sr proprietary ingredient TESTOFEN™ to evaluate its effect on muscle mass and Free Testosterone increase.
Participants on the active substance were on a dosage of 300 mg two times a day. The active group showed 98% increase in Free Testosterone levels. The increase in the active group was almost 100% compared to placebo.
In addition to an increase in free testosterone levels, subjects supplementing with TESTOFEN™ experienced significant reduction in skin fold thickness in the thigh and biceps regions without losing body weight, indicating a reduction of body fat and increase in muscle mass.
Subjects on TESTOFEN™ also demonstrated significant reductions in levels of Blood Urea Nitrogen [ BUN ] suggesting that TESTOFEN™ prevents Protein Catabolism. This parameter also confirms muscle mass build up.